These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3491421)

  • 21. Effect of UVB on alloactivating and antigen-presenting capacity of human epidermal Langerhans cells.
    Austad J; Braathen LR
    Scand J Immunol; 1985 May; 21(5):417-23. PubMed ID: 3873686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enriched Langerhans cells express more HLA-DR determinants than blood-derived adherent cells (monocytes and dendritic cells).
    Bjercke S; Gaudernack G; Braathen LR
    Scand J Immunol; 1985 May; 21(5):489-92. PubMed ID: 2408326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction.
    Thorsby E; Berle E; Scott H; Braathen LR
    Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-Dr-unrestricted accessory cell function in human neutrophils.
    Lukacs K; Cohen DA; Kaplan AM
    Clin Immunol Immunopathol; 1986 Mar; 38(3):344-9. PubMed ID: 3484684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons.
    Blauvelt A; Clerici M; Lucey DR; Steinberg SM; Yarchoan R; Walker R; Shearer GM; Katz SI
    J Immunol; 1995 Apr; 154(7):3506-15. PubMed ID: 7897231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes.
    Braathen LR; Thorsby E
    Scand J Immunol; 1982 Jan; 15(1):55-61. PubMed ID: 6176017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dendritic cells and monocytes as accessory cells in T-cell responses in man. II. Function as antigen-presenting cells.
    Bjercke S; Gaudernack G
    Scand J Immunol; 1985 May; 21(5):501-8. PubMed ID: 3873688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The crucial role of human dendritic antigen-presenting cell subsets in nickel-specific T-cell proliferation.
    Res P; Kapsenberg ML; Bos JD; Stiekema F
    J Invest Dermatol; 1987 May; 88(5):550-4. PubMed ID: 2437211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro.
    Furue M; Katz SI
    J Immunol; 1988 Jun; 140(12):4139-43. PubMed ID: 3259608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen.
    Shimada S; Caughman SW; Sharrow SO; Stephany D; Katz SI
    J Immunol; 1987 Oct; 139(8):2551-5. PubMed ID: 3498764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
    Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
    J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Langerhans cell production of interleukin-1.
    Sauder DN; Dinarello CA; Morhenn VB
    J Invest Dermatol; 1984 Jun; 82(6):605-7. PubMed ID: 6373957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells.
    Teunissen MB; De Jager MH; Kapsenberg ML; Bos JD
    Br J Dermatol; 1991 Oct; 125(4):309-16. PubMed ID: 1954118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro modulation of T6 expression on gingival Langerhans cells by interleukin-1 inhibitors and ETAF.
    Walsh LJ; Lander PE; Seymour GJ; Powell RN
    J Dent Res; 1987 Mar; 66(3):766-9. PubMed ID: 3112200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative efficiency of human Langerhans' cells and blood derived dendritic cells as antigen-presenting cells.
    Bjercke S; Braathen L; Gaudernack G; Thorsby E
    Acta Derm Venereol; 1985; 65(5):374-8. PubMed ID: 2416158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of human epidermal Langerhans cells in skin immunity.
    Braathen LR
    Derm Beruf Umwelt; 1987; 35(2):58-61. PubMed ID: 2439270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes.
    Thomas R; Davis LS; Lipsky PE
    J Immunol; 1993 Dec; 151(12):6840-52. PubMed ID: 8258694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.